CN1219514C - 具有高吸收性的口服制剂 - Google Patents

具有高吸收性的口服制剂 Download PDF

Info

Publication number
CN1219514C
CN1219514C CNB021439834A CN02143983A CN1219514C CN 1219514 C CN1219514 C CN 1219514C CN B021439834 A CNB021439834 A CN B021439834A CN 02143983 A CN02143983 A CN 02143983A CN 1219514 C CN1219514 C CN 1219514C
Authority
CN
China
Prior art keywords
vitamin
agent
tocopherol
present
bisbenzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021439834A
Other languages
English (en)
Chinese (zh)
Other versions
CN1411812A (zh
Inventor
冈田実
菅田晴夫
堀江敏彰
金子哲男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Publication of CN1411812A publication Critical patent/CN1411812A/zh
Application granted granted Critical
Publication of CN1219514C publication Critical patent/CN1219514C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CNB021439834A 2001-10-11 2002-09-29 具有高吸收性的口服制剂 Expired - Fee Related CN1219514C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP313977/2001 2001-10-11
JP2001313977A JP2003119141A (ja) 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤

Publications (2)

Publication Number Publication Date
CN1411812A CN1411812A (zh) 2003-04-23
CN1219514C true CN1219514C (zh) 2005-09-21

Family

ID=19132362

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021439834A Expired - Fee Related CN1219514C (zh) 2001-10-11 2002-09-29 具有高吸收性的口服制剂

Country Status (4)

Country Link
JP (1) JP2003119141A (https=)
KR (1) KR20030030882A (https=)
CN (1) CN1219514C (https=)
TW (1) TWI244921B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4780907B2 (ja) * 2003-09-30 2011-09-28 小林製薬株式会社 催眠剤組成物
JP4721631B2 (ja) * 2003-09-30 2011-07-13 小林製薬株式会社 催眠剤組成物
JP5094899B2 (ja) * 2010-03-23 2012-12-12 小林製薬株式会社 催眠剤組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151132A (ja) * 1984-12-24 1986-07-09 Kanebo Ltd ビタミンk↓2経口剤の製造法
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
JPH10130171A (ja) * 1996-09-04 1998-05-19 Dot:Kk 経口投与用医薬組成物
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Also Published As

Publication number Publication date
HK1054695A1 (en) 2003-12-12
JP2003119141A (ja) 2003-04-23
TWI244921B (en) 2005-12-11
CN1411812A (zh) 2003-04-23
KR20030030882A (ko) 2003-04-18

Similar Documents

Publication Publication Date Title
CA2716948C (en) Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients
JP5626890B2 (ja) リポ酸のペレット組成物
TW202025997A (zh) 正常化胺基酸代謝的方法
DE69935326T2 (de) Zusammensetzungen enthaltend molybden zur steigerung des proteinanabolismus und der entgiftung
JP5114399B2 (ja) 疲労予防及び/又は回復のための医薬
US20190151275A1 (en) Composition for treatment of neurodegenerative disease
CN1219514C (zh) 具有高吸收性的口服制剂
JPH10287560A (ja) 医薬組成物
CN100467038C (zh) 一种含多种维生素的护肝制剂的生物学药理学作用及其制备方法
US20090247496A1 (en) Pharmaceutical composition and extract of poria for enhancing uptake of nutrients
WO2022196943A2 (ko) 코엔자임 큐텐 함유 액상 보조사료 조성물
CN109602893A (zh) 一种改善肝损伤及机体疲劳的组合物及其制剂
JPH03204814A (ja) 腎不全用経口アミノ酸製剤
US20210128466A1 (en) Reduced volume formulations including amino acid entities
JPH07330593A (ja) 疲労改善剤
HK1054695B (en) Oral administration preparation improved in absorbability
JP5114394B2 (ja) 疲労回復のための医薬
JP2011068647A (ja) アスパラギン酸又はその塩含有固形製剤
Soni et al. Simultaneous determination of vitamins B1, B2 and B6 in multivitamin tablet and biological fluid by RP-HPLC
CN1244326C (zh) 抗疲劳药物组合物
WO2023220103A1 (en) Dietary supplement compositions
JP2022170992A (ja) 生薬等含有液状組成物
KR20230065181A (ko) 티아민 또는 그의 유도체와 피돌산 마그네슘을 포함하는 경구용 조성물 및 복합 제제
JP5533949B2 (ja) 疲労改善内服剤
JPH06247876A (ja) アルコール性肝障害軽減剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050921

Termination date: 20100929